Terapi Nebulasi pada Pasien Anak dengan Bronkiolitis
Abstract
This study aims to determine which nebulization therapy is effective for improving respiratory status and reducing the length of stay in children with bronchiolitis. The research method used was a literature search using six databases: PubMed, ProQuest, ScienceDirect, Scopus, Sage Journals, and Embase. The results of the study showed that the average age of the children who were respondents was 0-24 months. Eight articles showed that all therapy options could improve the child's respiratory status, but not all significantly reduced the length of stay. In conclusion, nebulization therapy that can be used in pediatric patients with bronchiolitis to improve the child's respiratory status includes hypertonic saline (HS), normal saline (NS), magnesium sulfate (MgSO4), interferon α1b (IFN α1b) In, In and In racemic epinephrine (RE). , while nebulized therapy that can reduce the length of stay is racemic epinephrine (RE) and hypertonic saline (HS).This study aims to determine which nebulization therapy is effective for improving respiratory status and reducing the length of stay in children with bronchiolitis. The research method used was a literature search using six databases: PubMed, ProQuest, ScienceDirect, Scopus, Sage Journals, and Embase. The results of the study showed that the average age of the children who were respondents was 0-24 months. Eight articles showed that all therapy options could improve the child's respiratory status, but not all significantly reduced the length of stay. In conclusion, nebulization therapy that can be used in pediatric patients with bronchiolitis to improve the child's respiratory status includes hypertonic saline (HS), normal saline (NS), magnesium sulfate (MgSO4), interferon α1b (IFN α1b) In, In and In racemic epinephrine (RE). , while nebulized therapy that can reduce the length of stay is racemic epinephrine (RE) and hypertonic saline (HS).
Keywords: Children, Bronchiolitis, Length of Hospitalization, Nebulization, Respiratory Status
References
Barati, L., Ali, S., Khosravi, M., & Azari, A. A. (2022). Comparison of the Effects of Salbutamol, Epinephrine, and 5% Inhaled Hypertonic Saline on Infants with Acute Bronchiolitis. Journal of Comprehensive Pediatrics 13(1), 1–6. https://doi.org/10.5812/compreped.120489
Beal, G., Barbier, C., Thoret, S., Rubio, A., Bonnet, M., Mazet, R., Ego, A., & Pin, I. (2019). Nebulized Hypertonic Saline 3% for 1 versus 3 Days in Hospitalized Bronchiolitis : A Blinded Non-Inferiority Randomized Controlled Trial. BMC Pediatrics 19, 1–7. https://doi.org/10.1186/s12887-019-1804-0
Buendía, J. A., & Patiño, D. G. (2022). Budget Impact Analysis of Hypertonic Saline Inhalations for Infant Bronchiolitis: The Colombian National Health System Perspective. Value in Health Regional Issues, 28, 14–18. https://doi.org/10.1016/j.vhri.2021.07.008
Chen, L., Shi, M., Deng, Q., Liu, W., Li, Q., Ye, P., Yu, X., Zhang, B., Xu, Y., Li, X., Yang, Y., Li, M., Cai, Q., Wang, L., Hu, B., Xie, L., Li, G., Xie, L., Liu, X., … Fu, Q. (2020). A Multi-Center Randomized Prospective Study on the Treatment of Infant Pronchiolitis with Interferon α1b Nebulization. Plos One 15(2), 1–11. https://doi.org/10.1371/journal.pone.0228391
Debbarma, R., & Khera, D. (2021). Nebulized Magnesium Sulphate in Bronchiolitis : A Randomized Controlled Trial. The Indian Journal of Pediatrics 88(11), 1080–1085. https://10.1007/s12098-021-03695-8
Jaquet-Pilloud, R., Verga, M., Russo, M., Gehri, M., & Pauchard, J. (2019). Nebulised Hypertonic Saline in Moderate-to-Severe Bronchiolitis : A Randomised Clinical Trial. BMJ 1–5. https://doi.org/10.1136/archdischild-2019-317160
Jat, K. R., Dsouza, J. M., & Mathew, J. L. (2022). Continuous Positive Airway Pressure (CPAP) for Acute Bronchiolitis in Children. Cochrane Database of Systematic Reviews, 2022(4). https://doi.org/10.1002/14651858.CD010473.pub4
Khoshnevisasl, P., Sadeghzadeh, M., Kamali, K., & Ardalani, A. (2022). A Randomized Clinical Trial to Assess the Effect of Zinc and Vitamin D Supplementation in Addition to Hypertonic Saline on Treatment of Acute Bronchiolitis. BMC Infectious Diseases, 22(1), 1–7. https://doi.org/10.1186/s12879-022-07492-2
Kirolos, A., Manti, S., Blacow, R., Tse, G., Wilson, T., Lister, M., Cunningham, S., Campbell, A., Nair, H., Reeves, R. M., Fernandes, R. M., Campbell, H., Nair, H., Reeves, R. M., Douglas, A., Cunningham, S., Meijer, A., Fischer, T. K., Heikkinen, T., & Molero, E. (2021). A Systematic Review of Clinical Practice Guidelines for the Diagnosis and Management of Bronchiolitis. Journal of Infectious Diseases, 2019(xx) 1-8. https://doi.org/10.1093/INFDIS/JIZ240
McLaren, S. H., Qi, Y., Espinola, J. A., Mansbach, J. M., Dayan, P. S., & Camargo, C. A. (2023). Factors Associated with Mild Bronchiolitis in Young Infants. Journal of the American College of Emergency Physicians Open, 4(3), 1–9. https://doi.org/10.1002/emp2.12966
Orzołek, I., Ambrożej, D., Makrinioti, H., Zhu, Z., Jartti, T., & Feleszko, W. (2023). Severe Bronchiolitis Profiling as the First Step Towards Prevention of Asthma. Allergologia et Immunopathologia, 51(3), 99–107. https://doi.org/10.15586/aei.v51i3.788
Osman, S., Alaadeen, A., Hetta, O., Alsiraihi, A., Bader, M., Aloufi, A., Abushouk, A., & Al-hindi, M. Y. (2023). Epidemiology and Risk Factor Analysis of Children with Bronchiolitis Admitted to the Intensive Care Unit at A Tertiary Care Center in Saudi Arabia. Children, 10(4). https://doi.org/10.3390/children10040646
Paluch, L. (2020). Identifying and Managing Bronchiolitis. Journal of the American Academy of Physician Assistants, 33(9), 12–15. https://doi.org/10.1097/01.JAA.0000694944.22382.39
Pukai, G., Duke, T., Pukai, G., & Duke, T. (2020). Nebulised Normal Saline in Moderate Acute Bronchiolitis and Pneumonia in A Low to Middle Income Country : A Randomised Trial in Papua New Guinea. Paediatrics and International Child Health, 00(00), 1–6. https://doi.org/10.1080/20469047.2020.1725338
Sapkota, S., Kaleem, A., Huma, S., Aleem, M., Din, U., Ahmad, S., & Shahalam, S. (2021). Comparison of 3% Saline and 0. 9% Normal Saline Nebulization as Diluent in Children with Bronchiolitis. JPMA 71(3), 822–825. https://doi.org/10.47391/JPMA.569
Song, Y., & Li, R. (2021). Effect of Budesonide Combined with Salbutamol Nebulization on Pulmonary Function and Serum Immune Factors in Children with Bronchiolitis. American Journal of Translational Research, 13(7), 8158–8164. https://pubmed.ncbi.nlm.nih.gov/34377300/
Szupieńko, S., Buczek, A., & Szymański, H. (2023). Nebulised 3% Hypertonic Saline Versus 0.9% Saline for Treating Patients Hospitalised with Acute Bronchiolitis: Protocol for A Randomised, Double-Blind, Multicentre Trial. BMJ Open, 13(11), 1–6. https://doi.org/10.1136/bmjopen-2023-080182
Yasin, F. (2020). Role of Nebulized Epinephrine in Moderate Bronchiolitis : A Quasi-Randomized Trial. Irish Journal of Medical Science 10–13. https://10.1007/s11845-020-02293-5
Zhang, L., Mendoza-Sassi, R. A., Wainwright, C. E., Aregbesola, A., & Klassen, T. P. (2023). Nebulised Hypertonic Saline Solution for Scute Bronchiolitis in Infants. Cochrane Database of Systematic Reviews, 2023(4). https://doi.org/10.1002/14651858.CD006458.pub5
Copyright (c) 2024 Gian Rasyiddin Muhammad, Allenidekania Allenidekania, Yeni Rustina
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
